ARTHRO Distension Plus Intensive Mobilisation in Shoulder Capsulitis
- Conditions
- Shoulder Capsulitis
- Interventions
- Procedure: ARTHRO distension plus intensive mobilisationProcedure: infiltration intra articular
- Registration Number
- NCT00724113
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
The purpose of this study is to evaluate the effectiveness of ARTHRO distension plus intensive mobilisation in shoulder capsulitis.
- Detailed Description
The aim of the study is to evaluate a treatment of shoulder capsulitis that associates ARTHRO distension and intensive mobilisation at 2, 6, 12, 26 and 52 weeks. It is a bicentric 87-month (inclusion: 74 months; follow up: 13 months) observer blind randomised clinical trial using 2 groups in parallel. The number of patients to be included is 66. The treatment that is evaluated associates ARTHRO distension followed by mobilisation of the shoulder 6 hours per day during 5 days, and then sessions of physiotherapy for 4 weeks. The control intervention is one intra-articular injection of corticosteroids and physiotherapy. The primary outcome is SPADI, namely pain and disability, at 2 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- age ≥ 18 years
- shoulder capsulitis
- duration of symptoms ≥ 3 months
- health insurance
- cognitive disorders
- Hypo coagulation
- biological inflammatory syndrome
- uncontrolled diabetes
- XYLOCAINE allergy
- pregnancy
- unable to understand and to speak french
- previous surgery of shoulder
- shoulder infiltration or distension in the previous month
- local contraindication to shoulder infiltration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 ARTHRO distension plus intensive mobilisation ARTHRO distension plus intensive mobilisation 1 infiltration intra articular infiltration intra articular
- Primary Outcome Measures
Name Time Method Pain and disability using SPADI score at 2 weeks at 2 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rheumatology department of Lariboisiere hospital
🇫🇷Paris, France